Editor's Note: From the Cyclooxygenase-2 Inhibitor Celecoxib to a Novel Class of 3-Phosphoinositide-Dependent Protein Kinase-1 Inhibitors.

Autor: Zhu J, Huang JW, Tseng PH, Yang YT, Fowble J, Shiau CW, Shaw YJ, Kulp SK, Chen CS
Jazyk: angličtina
Zdroj: Cancer research [Cancer Res] 2019 Apr 01; Vol. 79 (7), pp. 1716.
DOI: 10.1158/0008-5472.CAN-19-0502
Databáze: MEDLINE